SCHEMBL2802215

SCHEMBL2802215

O=C(O)c1cnn2c(Nc3cccc4ncccc34)c(C(=O)N3CCC(c4ccccc4)CC3)cnc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
PDE4B Q07343 2/20 0.41
SYK P43405 1/20 0.40
KDM4C Q9H3R0 1/20 0.40
SPR P35270 2/20 0.39
P2RX7 Q99572 2/20 0.38
MAPT P10636 1/20 0.38
SCD5 Q86SK9 2/20 0.38
CASP1 P29466 1/20 0.38
CCKBR P32239 1/20 0.37
TRPV1 Q8NER1 1/20 0.37
MEN1 O00255 1/20 0.37
TP53 P04637 1/20 0.37
CYP3A4 P08684 1/20 0.37
GAA P10253 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
CYP2C19 P33261 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2801512 0.90 HPGD (0.42) ALDH1A1PDE4BSPRMAPTTP53
SCHEMBL2800919 0.89 ALDH1A1 (0.38) ALDH1A1PDE4BSYKSPRP2RX7
SCHEMBL2800458 0.87 ALDH1A1 (0.41) ALDH1A1SYKSPRMAPTSCD5
SCHEMBL2800844 0.87 SPR (0.42) ALDH1A1PDE4BKDM4CSPRMAPT
SCHEMBL2801767 0.84 SPR (0.47) ALDH1A1SYKKDM4CSPRTRPV1
SCHEMBL2801102 0.84 SIRT5 (0.50) ALDH1A1SPRMAPTGAAHPGD
SCHEMBL2801085 0.84 PDE4B (0.44) ALDH1A1PDE4BSPRMAPTSCD5
SCHEMBL2798484 0.83 MGLL (0.47) ALDH1A1SYKSPR
SCHEMBL2798969 0.83 SCD5 (0.44) ALDH1A1SPRSCD5SIRT5SCD
SCHEMBL2801684 0.82 LMNA (0.45) ALDH1A1PDE4BSPRP2RX7MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2206714-B1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO LTD (JP) 2015-01-21 EP disclosed
US-8729264-B2 Agent for prevention and/or treatment of skin diseases KYOWA HAKKO KIRIN CO., LTD. (JP) 2014-05-20 US disclosed
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-10-07 US disclosed
EP-2206714-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES Kyowa Hakko Kirin Co., Ltd. (JP) 2010-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES TYR, CUTA, SERPINB1 ALDH1A1 243/4885PDE4B 1603/4885SYK 958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.